CoChat

Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections

Parkins, Michael D., Sabuda, Deana M., Elsayed, Sameer, Laupland, Kevin B. · 2007 · Journal of Antimicrobial Chemotherapy

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: Although inadequate antimicrobial therapy has been demonstrated in multiple studies to increase the risk for death in bacterial infections, few data investigating the effect of antifungal therapy on outcome of serious fungal disease are available. We sought to assess the adequacy of empirical therapy and its effect on mortality in invasive Candida species infections. METHODS: Population-based surveillance of all patients with Candida spp. cultured from blood and/or cerebrospinal fluid was conducted. Adequacy of empirical therapy was assessed according to published guidelines. RESULTS: During a 5 year period, 207 patients had an invasive Candida spp. infection identified; in 199 cases (96%) adequate data were available for assessment of treatment and outcome at hospital discharge. One hundred and three (52%) cases were due to Candida albicans, 44 (22%) were due to Candida glabrata and the remainder were due to other species. Between the time of culture draw and reporting of a positive culture, only 64 (32%) patients were treated with empirical therapy; this was deemed adequate in 51 (26%). Patients who received adequate empirical therapy had a significant decrease in crude mortality [14/51 (27%) versus 68/148 (46%); risk ratio 0.60 (95% confidence interval 0.37-0.96); P = 0.02]. After adjusting for age and the need for intensive care unit admission in logistic regression analysis, the use of adequate empirical therapy was independently associated with a reduced risk for death [odds ratio 0.46 (95% confidence interval 0.22-1.00); P = 0.05]. CONCLUSIONS: Adequate empirical therapy is used in a minority of patients with invasive Candida spp. infections but is associated with improved survival.

Overview

Integrity signals

Registry

Crossref · 10.1093/jac/dkm212

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 229

Metadata

Authors
Parkins, M. D., Sabuda, D. M., Elsayed, S., & Laupland, K. B.
Affiliations
University of Calgary (CA)
Corresponding author
Laupland, Kevin B.
Venue
Journal of Antimicrobial Chemotherapy
Published
2007-06-18
Volume
60
Issue
3
Pages
613-618
ISSN
  • 0305-7453 (ISSN-L)
  • 1460-2091
OpenAlex
W2137351193
Cited by
229
References
32
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 7 · 2021: 5 · 2020: 6 · 2019: 9 · 2018: 4 · 2017: 14 · 2016: 15 · 2015: 10 · 2014: 17 · 2013: 20 · 2012: 17
FWCI
13.00
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Antimicrobial Chemotherapy (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
Keywords
invasive candidiasis, empirical antifungal therapy, treatment adequacy, mortality, Candida albicans, Candida glabrata, fungemia, cerebrospinal fluid culture, guideline adherence
MeSH terms
Adult, Aged, Aged, 80 and over, Alberta, Analysis of Variance, Antifungal Agents, Calibration, Candida, Candidiasis, Female, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Terminology as Topic, Risk Factors, Cohort Studies, Logistic Models, Odds Ratio, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.